NCT00586118View on ClinicalTrials.gov

Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Recovery From SedationSevoflurane ConsumptionRenal FunctionHepatic FunctionCardioprotection
Interventions
DRUG

Sevoflurane

Sevoflurane sedation, 0.5-1 Vol%, continuously via syringe pump, up to 72 hours in ICU

DRUG

Propofol

Propofol, 1.5-3 mg/kgBW/h, continuously via syringe pump, up to 72 hours

All Listed Sponsors
collaborator

Universitätsmedizin Mannheim

OTHER

lead

Klinikum Ludwigshafen

OTHER

NCT00586118 - Inhalative Sedation in ICU With Sevoflurane Via Anaesthetic Conserving Device Compared to Propofol | Biotech Hunter | Biotech Hunter